SCHEMBL869967

SCHEMBL869967

N[C@H]1CC[C@@H](n2c(=O)c3cc(F)cnc3n(-c3cccc(-c4ccccc4)c3)c2=O)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.37
CYP3A4 P08684 3/20 0.37
SSTR2 P30874 1/20 0.37
USP2 O75604 4/20 0.36
ALDH1A1 P00352 3/20 0.36
CYP2C9 P11712 3/20 0.36
MAPK1 P28482 2/20 0.36
POLB P06746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TNF P01375 7/20 0.35
LITAF Q99732 7/20 0.35
TSHR P16473 4/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GRM1 Q13255 1/20 0.35
RIPK2 O43353 1/20 0.35
CYP2C19 P33261 3/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL869968 1.00 CYP1A2 (0.37) CYP1A2CYP3A4SSTR2USP2ALDH1A1
Hydrochloric Acid SCHEMBL870846 0.99 CYP1A2 (0.37) CYP1A2CYP3A4SSTR2USP2ALDH1A1
Hydrochloric Acid SCHEMBL870845 0.99 CYP1A2 (0.37) CYP1A2CYP3A4SSTR2USP2ALDH1A1
SCHEMBL870626 0.93 TNF (0.37) CYP1A2CYP3A4SSTR2TNFLITAF
SCHEMBL870627 0.93 TNF (0.37) CYP1A2CYP3A4SSTR2TNFLITAF
SCHEMBL8170051 0.91 KCNH2 (0.38) CYP1A2CYP3A4KCNH2
SCHEMBL8187441 0.90 USP30 (0.37) CYP1A2CYP3A4USP2ALDH1A1CYP2C9
SCHEMBL871887 0.90 USP30 (0.37) CYP1A2CYP3A4USP2ALDH1A1CYP2C9
SCHEMBL871888 0.90 USP30 (0.37) CYP1A2CYP3A4USP2ALDH1A1CYP2C9
SCHEMBL870247 0.89 RIPK2 (0.35) CYP1A2CYP3A4ALDH1A1MAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2106396-B1 CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS ALCON RES LTD (US) 2014-09-24 EP disclosed
EP-2106396-B1 CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS ALCON RES LTD (US) 2014-09-24 EP disclosed
US-20120077801-A1 Chemical Compounds 637 ALCON RESEARCH, LTD. 2012-03-29 US disclosed
US-20120077801-A1 Chemical Compounds 637 ALCON RESEARCH, LTD. 2012-03-29 US disclosed
US-20120077801-A1 Chemical Compounds 637 ALCON RESEARCH, LTD. 2012-03-29 US disclosed
US-20100204203-A1 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors ALCON RESEARCH, LTD. 2010-08-12 US disclosed
US-20100204203-A1 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors ALCON RESEARCH, LTD. 2010-08-12 US disclosed
US-20100204203-A1 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors ALCON RESEARCH, LTD. 2010-08-12 US disclosed
EP-2106396-A2 CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS AstraZeneca AB (SE) 2009-10-07 EP disclosed
US-20090124596-A1 Chemical Compounds 637 ALCON RESEARCH, LTD. 2009-05-14 US disclosed
US-20090124596-A1 Chemical Compounds 637 ALCON RESEARCH, LTD. 2009-05-14 US disclosed
US-20090124596-A1 Chemical Compounds 637 ALCON RESEARCH, LTD. 2009-05-14 US disclosed
WO-2008084223-A2 CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS ASTRAZENECA AB (SE) 2008-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077801-A1 Chemical Compounds 637 PDE4A, PDE4B, PDE3B CYP1A2 266/4885CYP3A4 116/4885SSTR2 2312/4885
US-20090124596-A1 Chemical Compounds 637 PDE4A, PDE4B, PDE3B CYP1A2 266/4885CYP3A4 116/4885SSTR2 2312/4885
US-20100204203-A1 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors PDE4A, PDE4B, PDE5A CYP1A2 274/4885CYP3A4 73/4885SSTR2 2478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.